Home
/
BIOADAPTIVES, INC.
/
Financials
/
Quarterly
BIOADAPTIVES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIOADAPTIVES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$4.6K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$3.2K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$0
May 13, 2025
Q3
2025
Sep 30, 2024
$0
Nov 14, 2025
Q2
2025
Jun 30, 2024
$675
Aug 14, 2025
Q1
2025
Mar 31, 2024
$12.0K
May 13, 2025
Q3
2024
Sep 30, 2023
$15.6K
Nov 19, 2024
Q2
2024
Jun 30, 2023
$2.3K
Aug 19, 2024
Q1
2024
Mar 31, 2023
$3.4K
May 17, 2024
Q3
2023
Sep 30, 2022
$3.3K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$4.3K
Aug 11, 2023
Q1
2023
Mar 31, 2022
$5.5K
May 12, 2023
Q3
2022
Sep 30, 2021
$5.3K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$6.1K
Aug 12, 2022
Q1
2022
Mar 31, 2021
$4.5K
May 12, 2022
Q3
2021
Sep 30, 2020
$4.4K
Nov 10, 2021
Q2
2021
Jun 30, 2020
$3.5K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$4.7K
May 14, 2021
Q3
2020
Sep 30, 2019
$2.1K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$5.2K
Aug 13, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$11.9K
Nov 18, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($379.5K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($157.9K)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($157.9K)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($197.1K)
May 13, 2025
Q2
2025
Mar 31, 2025
($197.1K)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($197.1K)
Nov 14, 2025
Q3
2025
Sep 30, 2024
($37.6K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($183.0K)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($183.0K)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($306.7K)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($306.7K)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($306.7K)
May 13, 2025
Q3
2024
Sep 30, 2023
($13.1K)
Nov 19, 2024
Q3
2024
Jun 30, 2023
($143.9K)
Nov 19, 2024
Q2
2024
Jun 30, 2023
($143.9K)
Aug 19, 2024
Q2
2024
Mar 31, 2023
($287.2K)
Aug 19, 2024
Q1
2024
Mar 31, 2023
($287.2K)
May 17, 2024
Q3
2024
Mar 31, 2023
($287.2K)
Nov 19, 2024
Q3
2023
Sep 30, 2022
($276.3K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($223.8K)
Aug 11, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($265.7K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($279.2K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($249.1K)
May 13, 2025
Q3
2025
Sep 30, 2024
($121.9K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($93.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($49.8K)
May 13, 2025
Q3
2024
Sep 30, 2023
($92.2K)
Nov 19, 2024
Q2
2024
Jun 30, 2023
($55.9K)
Aug 19, 2024
Q1
2024
Mar 31, 2023
($19.0K)
May 17, 2024
Q3
2016
Sep 30, 2016
($26.3K)
Nov 18, 2016
Q2
2016
Jun 30, 2016
($33.2K)
Aug 18, 2016
Q1
2016
Mar 31, 2016
($80.9K)
May 23, 2016
Q3
2016
Sep 30, 2015
($40.1K)
Nov 18, 2016
Q2
2016
Jun 30, 2015
($109.4K)
Aug 18, 2016
Q1
2016
Mar 31, 2015
($29.3K)
May 23, 2016
Q3
2015
Sep 30, 2014
($22.3K)
Nov 23, 2015
Q2
2015
Jun 30, 2014
($107.5K)
Aug 21, 2015
Q1
2015
Mar 31, 2014
($8.4K)
May 20, 2015
Q3
2014
Sep 30, 2013
($1.2K)
Nov 14, 2014
Q2
2014
Jun 30, 2013
($1.5K)
Aug 14, 2014